Alibi, thanks for the pics of the Lab and your agreement on the quality of this investment. Below is a copy of a post I made on this Board a few weeks ago and Matt's response as I sent him a copy. I don't think he would mind me posting this:
"Thank you for posting this. I certainly think you are on target, but cannot confirm or deny."
All the Best,
Matthew L. Schissler
Chairman & CEO
Cord Blood America, Inc. (publicly traded on the NASDAQ OTCBB: Symbol CBAI)
From: Dew *
Sent: Friday, September 04, 2009 5:40 PM
To: mls@cordpartners.com
Subject: RE: Hey Matt
I just posted this on the Ihub website. I think you would agree this is possible but no answer needed. Take care.
Dew
IMO. For people looking for a great investment. This stock is a steal right now. Imagine the following:
First of all, Matt (Cord Blood CEO) has never had the buying power he has now. He almost has a clean balance sheet and he has $7.5M of equity funding available whenever he needs it. The dilution will soon be over. They have the new Lab and got a great price for it, immediatly improving the gross profit. Say this shows up in the 1Q 2010 results. He is currently #4 of 20 competitors according to him. So he will either be trying to gobble up smaller companies or at least offering leasing services to those currently storing stem cells in other places, or just getting started like all these new stem cell banks popping up. They will for sure be cash flow positive by 1Q 2010. And as I posted earlier they will save 15+% of revenue once the collection patent expires March 2010. So I predict they will be profitable in 2Q 2010. Any positive EPS will guarantee this stock will reach at least 15 times multiple or at least $.10+ a share.
Now if you bought 10M shares today for about $30K, once they obtain a postivie EPS this stock will soar to at least 10 cents a share no doubt. With a $30K investment equalling 10M shares, at $.10 you become a millionare. I say no later than September 2010.
Other thoughts welcome.
GLTA
AI
